Goldman Sachs, the International Finance Corporation, and Motilal Oswal Group are involved in the Initial Public Offering of Molbio Diagnostics.
6 reports, 2 independent
Updated Sep 10
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 6
- Developments
- 2
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Goldman Sachs, the International Finance Corporation, and Motilal Oswal Group are involved in the Initial Public Offering of Molbio Diagnostics.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.GS and IFC invest in Molbio Diagnostics IPO alongside Motilal Oswal.1 source
GMP signals strong investor interest in the IPO of Molbio Diagnostics.1 source
Keep exploring
The entities involved
-
Molbio Diagnostics
Nothing else this week.
-
Goldman Sachs
American investment bank
-
International Finance Corporation
World Bank Group member financial institution
Related events
- Both Molbio Diagnostics and Tempsens showed strong IPO performance on August 1, 2026.
- Goldman Sachs, Abu Dhabi Investment Authority, and Vanguard are involved in an IPO anchor book as global institutional investors.
- Goldman Sachs is advising on an IPO and discussing strategic opportunities in India.
- IPO offering structure announced for Accelevation/Miamisburg on Nasdaq, targeting $5.37 billion valuation, with Goldman Sachs involved.
- Aditya Birla Sun Life Mutual Fund, Goldman Sachs, and Capital Group acquired shares in Granules India, while a promoter offloaded shares.